ArticleOpen medicine (Warsaw, Poland)2026
Efficacy and safety of obinutuzumab as rescue therapy for rituximab-resistant and rituximab-recurrent primary membranous nephropathy: a retrospective cohort study.
Li Tian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.